When To Scrap Your Process And Go To A CDMO Platform

Roche/Genentech unveiled plans for a $700m-plus manufacturing facility for weight loss drugs in North Carolina as President Trump signaled such investments could mean no tariffs for pharma.

Dr. Reddy's Laboratories preps for potential US tariffs, focusing on sustaining product supply and collaborating with customers on inventories. A recent US plant sale, the firm stressed, was unrelated to tariffs and underlines its openness to ‘make in the US’, where it launched 18 products in fiscal 2025.

Workforce development will be essential to meeting president Trump’s goal to return biopharma manufacturing to the US.

An ‘historic economic prosperity deal’ does not include the sector.